ingevity. First Quarter 2021 Earnings Presentation April 29, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, res ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-K ______________________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-375 ...

Ingevity Corporation (NYSE:NGVT) Q4 2020 Earnings Conference Call February 11, 2021 10:00 AM ET Company Participants Jack Maurer - SVP of Public Affairs & IR John Fortson - President, CEO, Interim CFO Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Bill Hamilton - Vice President of Financial Planning and Analysis and Treasury Erik Ripple - Chief Growth and Innovation Officer Conference Call Participants John McNulty - BMO Capital Markets Ian Zaffino - Oppenhe ...

Fourth Quarter 2020 Earnings Presentation February 11, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, results o ...

Ingevity Corporation (NYSE:NGVT) Q3 2020 Results Conference Call October 29, 2020 10:00 AM ET Company Participants Jack Maurer - VP of Public Affairs & IR John Fortson - President, CEO, Interim CFO Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Bill Hamilton - Vice President of Financial Planning and Analysis and Treasury Conference Call Participants Ian Zaffino - Oppenheimer Peter Lukas - CJS Securities Richard Garchitorena - Wells Fargo John McNulty - BMO ...

| --- | --- | --- | --- | |-------|-----------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third Quarter 2020 | | | | | | | | | | Earnings Presentation | | | | | | | | | | October 29, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 __________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 _______________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...